Detalhe da pesquisa
1.
pH Dependence of a GPR4 Selective Antagonist Hampers Its Therapeutic Potential.
J Pharmacol Exp Ther
; 386(1): 35-44, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142444
2.
Metabolite profiles of degarelix, a new gonadotropin-releasing hormone receptor antagonist, in rat, dog, and monkey.
Drug Metab Dispos
; 39(10): 1895-903, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768273
3.
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors.
Eur J Pharmacol
; 583(1): 62-72, 2008 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-18282565
4.
Additive effect of simultaneous continuous administration of degarelix and TAK-448 on LH suppression in a castrated rat model.
Eur J Pharmacol
; 824: 24-29, 2018 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378196